Actinium Pharmaceuticals reported $90K in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AbbVie USD 16.99B 1.99B Jun/2026
Actinium Pharmaceuticals USD 90K 9K Sep/2025
Amgen USD 10.1B 1.48B Jun/2026
Bioline Rx USD 477K 283K Mar/2026
Capricor Therapeutics USD 11.13M 8.87M Dec/2024
Pfizer USD 15.03B 530M Jun/2026